These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 2926140)

  • 21. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.
    Yagawa K; Kaku M; Ichinose Y; Nagao S; Tanaka A; Aida Y; Tomoda A
    J Immunol; 1985 Jun; 134(6):3705-11. PubMed ID: 2985692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
    Reisser D; Jeannin JF; Lagadec P; Martin F
    J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
    Sone S; Mutsuura S; Ogawara M; Tsubura E
    J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C; Temime N; Charron DJ; Parant MA
    J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes.
    Dijkstra J; Mellors JW; Ryan JL; Szoka FC
    J Immunol; 1987 Apr; 138(8):2663-70. PubMed ID: 3494081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S; Tsubura E
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocytic and tumoricidal heterogeneity of rat liver macrophage populations.
    Daemen T; Veninga A; Roerdink FH; Scherphof GL
    Sel Cancer Ther; 1989; 5(4):157-67. PubMed ID: 2623381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma-interferon supplemented with lipopolysaccharide or muramyldipeptide.
    Stukart MJ; Rijnsent A; Roos E
    Cancer Res; 1987 Jul; 47(14):3880-5. PubMed ID: 3109735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
    Sone S; Poste G; Fidler IJ
    J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity.
    Gardner CR; Wasserman AJ; Laskin DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6686-91. PubMed ID: 3119198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 affects differently the release of inflammatory mediators from resident macrophages by LPS and muramyl tripeptides.
    Dieter P; Hempel U; Kamionka S; Kolada A; Malessa B; Fitzke E; Tran-Thi TA
    Mediators Inflamm; 1999; 8(6):295-303. PubMed ID: 10815618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K; Das PK
    J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells.
    Sakita M; Kageyama N; Majima S
    Oncology; 1985; 42(4):259-64. PubMed ID: 4011111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomal phosphatidylserine inhibits tumor cytotoxicity of liver macrophages induced by muramyl dipeptide and lipopolysaccharide.
    Daemen T; Regts J; Scherphof GL
    Biochim Biophys Acta; 1996 Dec; 1285(2):219-28. PubMed ID: 8972706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers: cytotoxic factor production.
    Petit C; Monsigny M; Roche AC
    J Biol Response Mod; 1990 Feb; 9(1):33-43. PubMed ID: 2319259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
    Mace KF; Ehrke MJ; Hori K; Maccubbin DL; Mihich E
    Cancer Res; 1988 Oct; 48(19):5427-32. PubMed ID: 3416299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G; Kirsh R; Fogler WE; Fidler IJ
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.